The Perfect Enemy | JNJ stock falls as company is scaling back COVID-19 vaccine production (NYSE:JNJ) - Seeking Alpha
February 2, 2023

JNJ stock falls as company is scaling back COVID-19 vaccine production (NYSE:JNJ) – Seeking Alpha

JNJ stock falls as company is scaling back COVID-19 vaccine production (NYSE:JNJ)  Seeking AlphaView Full Coverage on Google News

Read Time:1 Minute

Scott Olson/Getty Images News

Amid falling demand, Johnson & Johnson (NYSE:JNJ) has significantly cut back the production of its COVID-19 vaccine and terminated manufacturing agreements with companies such as Catalent (NYSE:CTLT) and Sanofi (NASDAQ: